ID   TIAM2_HUMAN             Reviewed;        1701 AA.
AC   Q8IVF5; B2RP56; C9JZV2; Q6NXN9; Q6ZUP9; Q9UFG6; Q9UKV9; Q9UKW0;
DT   05-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 4.
DT   28-JUN-2023, entry version 161.
DE   RecName: Full=Rho guanine nucleotide exchange factor TIAM2 {ECO:0000305|PubMed:10512681};
DE   AltName: Full=SIF and TIAM1-like exchange factor;
DE   AltName: Full=T-lymphoma invasion and metastasis-inducing protein 2;
DE            Short=TIAM-2;
GN   Name=TIAM2; Synonyms=KIAA2016, STEF;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), NUCLEOTIDE SEQUENCE [MRNA] OF
RP   634-1701 (ISOFORM 5), FUNCTION, TISSUE SPECIFICITY, AND VARIANT PRO-1089.
RX   PubMed=10512681; DOI=10.1006/geno.1999.5936;
RA   Chiu C.-Y., Leng S., Martin K.A., Kim E., Gorman S., Duhl D.M.;
RT   "Cloning and characterization of T-cell lymphoma invasion and metastasis 2
RT   (TIAM2), a novel guanine nucleotide exchange factor related to TIAM1.";
RL   Genomics 61:66-73(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT PRO-1089.
RC   TISSUE=Brain;
RA   Nagase T., Kikuno R., Ohara O.;
RT   "The nucleotide sequence of a long cDNA clone isolated from human.";
RL   Submitted (NOV-2002) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4), AND VARIANT PRO-1089.
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3), AND VARIANT
RP   PRO-1089.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 446-1701 (ISOFORM 2), AND VARIANT
RP   PRO-1089.
RC   TISSUE=Fetal brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
CC   -!- FUNCTION: Modulates the activity of RHO-like proteins and connects
CC       extracellular signals to cytoskeletal activities. Acts as a GDP-
CC       dissociation stimulator protein that stimulates the GDP-GTP exchange
CC       activity of RHO-like GTPases and activates them. Mediates extracellular
CC       laminin signals to activate Rac1, contributing to neurite growth.
CC       Involved in lamellipodial formation and advancement of the growth cone
CC       of embryonic hippocampal neurons. Promotes migration of neurons in the
CC       cerebral cortex. When overexpressed, induces membrane ruffling
CC       accompanied by the accumulation of actin filaments along the altered
CC       plasma membrane (By similarity). Activates specifically RAC1, but not
CC       CDC42 and RHOA. {ECO:0000250, ECO:0000269|PubMed:10512681}.
CC   -!- SUBUNIT: Interacts with MAP1A, MAP1B, PARP1 and YWHAE. Interacts with
CC       CD44, PARD3 and MAPK8IP2 (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q6ZPF3}. Cell
CC       projection, lamellipodium {ECO:0000250|UniProtKB:Q6ZPF3}. Cell
CC       projection, filopodium {ECO:0000250|UniProtKB:Q6ZPF3}. Cell projection,
CC       growth cone {ECO:0000250|UniProtKB:Q6ZPF3}. Cell projection, neuron
CC       projection {ECO:0000250|UniProtKB:Q6ZPF3}. Perikaryon
CC       {ECO:0000250|UniProtKB:Q6ZPF3}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=Q8IVF5-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8IVF5-2; Sequence=VSP_030975;
CC       Name=3; Synonyms=Short;
CC         IsoId=Q8IVF5-3; Sequence=VSP_030971;
CC       Name=4;
CC         IsoId=Q8IVF5-4; Sequence=VSP_030972;
CC       Name=5; Synonyms=Long;
CC         IsoId=Q8IVF5-5; Sequence=VSP_030974;
CC   -!- TISSUE SPECIFICITY: Expressed in the occipital, frontal and temporal
CC       lobes, cerebellum, putamen and testis. {ECO:0000269|PubMed:10512681}.
CC   -!- DOMAIN: The PH 1 domain and amino acids 621-782 (a region called TSS;
CC       otherwise known as CC-Ex) are necessary for membrane localization. The
CC       PH 1 and TSS domains are necessary for Rac1 activity. The PH 2 domain
CC       is engaged in the enhancement of the catalytic activity of the adjacent
CC       DH domain. The PH 1, TSS and DH domains are necessary to induce
CC       neurite-like structure (By similarity). {ECO:0000250}.
CC   -!- PTM: Phosphorylated on serine and threonine residues. Phosphorylated on
CC       Thr-1648 by Rho-kinase. Its phosphorylation by Rho-kinase inhibits its
CC       guanine nucleotide exchange activity, its interaction with MAP1A,
CC       MAP1B, PARP1 and YWHAE and reduces its ability to promote neurite
CC       growth (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the TIAM family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF05900.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAC23112.2; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAC86170.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF120323; AAF05900.1; ALT_INIT; mRNA.
DR   EMBL; AF120324; AAF05901.1; -; mRNA.
DR   EMBL; AB095936; BAC23112.2; ALT_INIT; mRNA.
DR   EMBL; AL122086; CAB59259.2; -; mRNA.
DR   EMBL; AL139101; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL355343; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL596202; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471051; EAW47693.1; -; Genomic_DNA.
DR   EMBL; BC066979; AAH66979.1; -; mRNA.
DR   EMBL; BC137275; AAI37276.1; -; mRNA.
DR   EMBL; AK125459; BAC86170.1; ALT_INIT; mRNA.
DR   CCDS; CCDS34558.1; -. [Q8IVF5-1]
DR   CCDS; CCDS34559.1; -. [Q8IVF5-3]
DR   RefSeq; NP_001010927.1; NM_001010927.2. [Q8IVF5-3]
DR   RefSeq; NP_036586.2; NM_012454.3. [Q8IVF5-1]
DR   AlphaFoldDB; Q8IVF5; -.
DR   SMR; Q8IVF5; -.
DR   BioGRID; 117621; 12.
DR   IntAct; Q8IVF5; 9.
DR   MINT; Q8IVF5; -.
DR   STRING; 9606.ENSP00000437188; -.
DR   GlyGen; Q8IVF5; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q8IVF5; -.
DR   PhosphoSitePlus; Q8IVF5; -.
DR   BioMuta; TIAM2; -.
DR   DMDM; 296453025; -.
DR   jPOST; Q8IVF5; -.
DR   MassIVE; Q8IVF5; -.
DR   MaxQB; Q8IVF5; -.
DR   PaxDb; Q8IVF5; -.
DR   PeptideAtlas; Q8IVF5; -.
DR   ProteomicsDB; 70693; -. [Q8IVF5-1]
DR   ProteomicsDB; 70694; -. [Q8IVF5-2]
DR   ProteomicsDB; 70695; -. [Q8IVF5-3]
DR   ProteomicsDB; 70696; -. [Q8IVF5-4]
DR   ProteomicsDB; 70697; -. [Q8IVF5-5]
DR   Antibodypedia; 2773; 199 antibodies from 25 providers.
DR   DNASU; 26230; -.
DR   Ensembl; ENST00000275246.11; ENSP00000275246.7; ENSG00000146426.19. [Q8IVF5-3]
DR   Ensembl; ENST00000360366.8; ENSP00000353528.4; ENSG00000146426.19. [Q8IVF5-5]
DR   Ensembl; ENST00000456877.6; ENSP00000407183.2; ENSG00000146426.19. [Q8IVF5-4]
DR   Ensembl; ENST00000461783.7; ENSP00000437188.2; ENSG00000146426.19. [Q8IVF5-1]
DR   Ensembl; ENST00000529824.6; ENSP00000433348.2; ENSG00000146426.19. [Q8IVF5-2]
DR   Ensembl; ENST00000682666.1; ENSP00000507157.1; ENSG00000146426.19. [Q8IVF5-1]
DR   GeneID; 26230; -.
DR   KEGG; hsa:26230; -.
DR   MANE-Select; ENST00000682666.1; ENSP00000507157.1; NM_012454.4; NP_036586.3.
DR   UCSC; uc003qqb.3; human. [Q8IVF5-1]
DR   AGR; HGNC:11806; -.
DR   CTD; 26230; -.
DR   DisGeNET; 26230; -.
DR   GeneCards; TIAM2; -.
DR   HGNC; HGNC:11806; TIAM2.
DR   HPA; ENSG00000146426; Tissue enhanced (brain, testis).
DR   MIM; 604709; gene.
DR   neXtProt; NX_Q8IVF5; -.
DR   OpenTargets; ENSG00000146426; -.
DR   PharmGKB; PA36515; -.
DR   VEuPathDB; HostDB:ENSG00000146426; -.
DR   eggNOG; KOG3519; Eukaryota.
DR   GeneTree; ENSGT00940000157012; -.
DR   HOGENOM; CLU_000494_2_1_1; -.
DR   InParanoid; Q8IVF5; -.
DR   OMA; KSHQPYA; -.
DR   OrthoDB; 25601at2759; -.
DR   PhylomeDB; Q8IVF5; -.
DR   TreeFam; TF319686; -.
DR   PathwayCommons; Q8IVF5; -.
DR   Reactome; R-HSA-193648; NRAGE signals death through JNK.
DR   Reactome; R-HSA-1989781; PPARA activates gene expression.
DR   Reactome; R-HSA-416482; G alpha (12/13) signalling events.
DR   Reactome; R-HSA-9013149; RAC1 GTPase cycle.
DR   SignaLink; Q8IVF5; -.
DR   SIGNOR; Q8IVF5; -.
DR   BioGRID-ORCS; 26230; 18 hits in 1148 CRISPR screens.
DR   ChiTaRS; TIAM2; human.
DR   GenomeRNAi; 26230; -.
DR   Pharos; Q8IVF5; Tbio.
DR   PRO; PR:Q8IVF5; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; Q8IVF5; protein.
DR   Bgee; ENSG00000146426; Expressed in cortical plate and 167 other tissues.
DR   ExpressionAtlas; Q8IVF5; baseline and differential.
DR   Genevisible; Q8IVF5; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0030175; C:filopodium; IEA:UniProtKB-SubCell.
DR   GO; GO:0030426; C:growth cone; IEA:UniProtKB-SubCell.
DR   GO; GO:0030027; C:lamellipodium; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; IBA:GO_Central.
DR   GO; GO:0043204; C:perikaryon; IEA:UniProtKB-SubCell.
DR   GO; GO:0045202; C:synapse; IBA:GO_Central.
DR   GO; GO:0005096; F:GTPase activator activity; IEA:Ensembl.
DR   GO; GO:0005085; F:guanyl-nucleotide exchange factor activity; TAS:Reactome.
DR   GO; GO:0090630; P:activation of GTPase activity; IBA:GO_Central.
DR   GO; GO:0050772; P:positive regulation of axonogenesis; IBA:GO_Central.
DR   GO; GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome.
DR   GO; GO:0007264; P:small GTPase mediated signal transduction; IBA:GO_Central.
DR   CDD; cd00992; PDZ_signaling; 1.
DR   CDD; cd01230; PH1_Tiam1_2; 1.
DR   CDD; cd01255; PH2_Tiam1_2; 1.
DR   CDD; cd00160; RhoGEF; 1.
DR   Gene3D; 2.30.42.10; -; 1.
DR   Gene3D; 6.10.140.680; -; 1.
DR   Gene3D; 1.20.900.10; Dbl homology (DH) domain; 1.
DR   Gene3D; 2.30.29.30; Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB); 2.
DR   InterPro; IPR035899; DBL_dom_sf.
DR   InterPro; IPR000219; DH-domain.
DR   InterPro; IPR001331; GDS_CDC24_CS.
DR   InterPro; IPR001478; PDZ.
DR   InterPro; IPR036034; PDZ_sf.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR003116; RBD_dom.
DR   InterPro; IPR043537; Tiam1/Tiam2/Sif.
DR   InterPro; IPR040655; TIAM1_CC-Ex.
DR   PANTHER; PTHR46001:SF5; RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR TIAM2; 1.
DR   PANTHER; PTHR46001; TIAM (MAMMALIAN TUMOR INVASION AND METASTASIS FACTOR) HOMOLOG; 1.
DR   Pfam; PF00595; PDZ; 1.
DR   Pfam; PF00169; PH; 1.
DR   Pfam; PF00621; RhoGEF; 1.
DR   Pfam; PF18385; Tiam_CC_Ex; 1.
DR   SMART; SM00228; PDZ; 1.
DR   SMART; SM00233; PH; 2.
DR   SMART; SM00455; RBD; 1.
DR   SMART; SM00325; RhoGEF; 1.
DR   SUPFAM; SSF48065; DBL homology domain (DH-domain); 1.
DR   SUPFAM; SSF50156; PDZ domain-like; 1.
DR   SUPFAM; SSF50729; PH domain-like; 2.
DR   PROSITE; PS00741; DH_1; 1.
DR   PROSITE; PS50010; DH_2; 1.
DR   PROSITE; PS50106; PDZ; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS50898; RBD; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Cell projection; Coiled coil; Cytoplasm;
KW   Guanine-nucleotide releasing factor; Lipoprotein; Myristate;
KW   Phosphoprotein; Reference proteome; Repeat.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000255"
FT   CHAIN           2..1701
FT                   /note="Rho guanine nucleotide exchange factor TIAM2"
FT                   /id="PRO_0000317467"
FT   DOMAIN          506..620
FT                   /note="PH 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   DOMAIN          810..881
FT                   /note="RBD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00262"
FT   DOMAIN          890..976
FT                   /note="PDZ"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   DOMAIN          1099..1293
FT                   /note="DH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00062"
FT   DOMAIN          1347..1478
FT                   /note="PH 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   REGION          1..21
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          201..250
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          265..293
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          389..417
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1070..1092
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1500..1556
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1568..1628
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          628..695
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        201..215
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        222..250
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        389..410
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1500..1546
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1568..1582
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1592..1607
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         1583
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6ZPF3"
FT   MOD_RES         1648
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6ZPF3"
FT   LIPID           2
FT                   /note="N-myristoyl glycine"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         1..1075
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:10512681,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_030971"
FT   VAR_SEQ         1..688
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_030972"
FT   VAR_SEQ         787
FT                   /note="Q -> QIFDSSGSHGFSGTQLPQNSSNSSE (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:10512681"
FT                   /id="VSP_030974"
FT   VAR_SEQ         1317
FT                   /note="E -> EQPEWSSEVMDVLDPRGKLTKGTLEEPRTL (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_030975"
FT   VARIANT         332
FT                   /note="R -> H (in dbSNP:rs931312)"
FT                   /id="VAR_051994"
FT   VARIANT         913
FT                   /note="R -> H (in dbSNP:rs7770537)"
FT                   /id="VAR_051995"
FT   VARIANT         1089
FT                   /note="S -> P (in dbSNP:rs4259257)"
FT                   /evidence="ECO:0000269|PubMed:10512681,
FT                   ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:17974005, ECO:0000269|Ref.2"
FT                   /id="VAR_051996"
FT   VARIANT         1101
FT                   /note="R -> C (in dbSNP:rs11751128)"
FT                   /id="VAR_038534"
FT   VARIANT         1572
FT                   /note="D -> E (in dbSNP:rs1571767)"
FT                   /id="VAR_038535"
FT   CONFLICT        506
FT                   /note="V -> A (in Ref. 7; BAC86170)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        633
FT                   /note="L -> P (in Ref. 1; AAF05900)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        722
FT                   /note="L -> P (in Ref. 1; AAF05900)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        807
FT                   /note="A -> T (in Ref. 1; AAF05900)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1066
FT                   /note="R -> K (in Ref. 7; BAC86170)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1092
FT                   /note="R -> G (in Ref. 6; AAH66979)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1154
FT                   /note="Q -> R (in Ref. 6; AAH66979)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1186
FT                   /note="S -> P (in Ref. 7; BAC86170)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1306
FT                   /note="Q -> R (in Ref. 7; BAC86170)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1365
FT                   /note="E -> K (in Ref. 7; BAC86170)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1376
FT                   /note="N -> Y (in Ref. 6; AAH66979)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1451
FT                   /note="R -> S (in Ref. 6; AAH66979)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1482
FT                   /note="R -> G (in Ref. 6; AAH66979)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1519
FT                   /note="D -> Y (in Ref. 7; BAC86170)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1639
FT                   /note="A -> T (in Ref. 7; BAC86170)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1701 AA;  190103 MW;  C2C9C9B1782B7823 CRC64;
     MGNSDSQYTL QGSKNHSNTI TGAKQIPCSL KIRGIHAKEE KSLHGWGHGS NGAGYKSRSL
     ARSCLSHFKS NQPYASRLGG PTCKVSRGVA YSTHRTNAPG KDFQGISAAF STENGFHSVG
     HELADNHITS RDCNGHLLNC YGRNESIAST PPGEDRKSPR VLIKTLGKLD GCLRVEFHNG
     GNPSKVPAED CSEPVQLLRY SPTLASETSP VPEARRGSSA DSLPSHRPSP TDSRLRSSKG
     SSLSSESSWY DSPWGNAGEL SEAEGSFLAP GMPDPSLHAS FPPGDAKKPF NQSSSLSSLR
     ELYKDANLGS LSPSGIRLSD EYMGTHASLS NRVSFASDID VPSRVAHGDP IQYSSFTLPC
     RKPKAFVEDT AKKDSLKARM RRISDWTGSL SRKKRKLQEP RSKEGSDYFD SRSDGLNTDV
     QGSSQASAFL WSGGSTQILS QRSESTHAIG SDPLRQNIYE NFMRELEMSR TNTENIETST
     ETAESSSESL SSLEQLDLLF EKEQGVVRKA GWLFFKPLVT VQKERKLELV ARRKWKQYWV
     TLKGCTLLFY ETYGKNSMDQ SSAPRCALFA EDSIVQSVPE HPKKENVFCL SNSFGDVYLF
     QATSQTDLEN WVTAVHSACA SLFAKKHGKE DTLRLLKNQT KNLLQKIDMD SKMKKMAELQ
     LSVVSDPKNR KAIENQIQQW EQNLEKFHMD LFRMRCYLAS LQGGELPNPK SLLAAASRPS
     KLALGRLGIL SVSSFHALVC SRDDSALRKR TLSLTQRGRN KKGIFSSLKG LDTLARKGKE
     KRPSITQVDE LLHIYGSTVD GVPRDNAWEI QTYVHFQDNH GVTVGIKPEH RVEDILTLAC
     KMRQLEPSHY GLQLRKLVDD NVEYCIPAPY EYMQQQVYDE IEVFPLNVYD VQLTKTGSVC
     DFGFAVTAQV DERQHLSRIF ISDVLPDGLA YGEGLRKGNE IMTLNGEAVS DLDLKQMEAL
     FSEKSVGLTL IARPPDTKAT LCTSWSDSDL FSRDQKSLLP PPNQSQLLEE FLDNFKKNTA
     NDFSNVPDIT TGLKRSQTDG TLDQVSHREK MEQTFRSAEQ ITALCRSFND SQANGMEGPR
     ENQDPPPRSL ARHLSDADRL RKVIQELVDT EKSYVKDLSC LFELYLEPLQ NETFLTQDEM
     ESLFGSLPEM LEFQKVFLET LEDGISASSD FNTLETPSQF RKLLFSLGGS FLYYADHFKL
     YSGFCANHIK VQKVLERAKT DKAFKAFLDA RNPTKQHSST LESYLIKPVQ RVLKYPLLLK
     ELVSLTDQES EEHYHLTEAL KAMEKVASHI NEMQKIYEDY GTVFDQLVAE QSGTEKEVTE
     LSMGELLMHS TVSWLNPFLS LGKARKDLEL TVFVFKRAVI LVYKENCKLK KKLPSNSRPA
     HNSTDLDPFK FRWLIPISAL QVRLGNPAGT ENNSIWELIH TKSEIEGRPE TIFQLCCSDS
     ESKTNIVKVI RSILRENFRR HIKCELPLEK TCKDRLVPLK NRVPVSAKLA SSRSLKVLKN
     SSSNEWTGET GKGTLLDSDE GSLSSGTQSS GCPTAEGRQD SKSTSPGKYP HPGLADFADN
     LIKESDILSD EDDDHRQTVK QGSPTKDIEI QFQRLRISED PDVHPEAEQQ PGPESGEGQK
     GGEQPKLVRG HFCPIKRKAN STKRDRGTLL KAQIRHQSLD SQSENATIDL NSVLEREFSV
     QSLTSVVSEE CFYETESHGK S
//
